Dr Sam Jackson


Programme Manager – Disease models, efficacy and safety pharmacology



Email address


Sam leads our programmes on disease models, efficacy and safety pharmacology. He is a member of the Science and Technology Group.

View Sam's Office-led projects

NC3Rs publications

Mead, A.N., et al. (2016). Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials. Regul Toxicol Pharmacol 80 348-57. DOI: 10.1016/j.yrtph.2016.05.002.

Jackson, S.J., et al. (2017). Does age matter? The impact of rodent age on study outcomes. Laboratory animals 51 (2): 160-169. DOI: 10.1177/0023677216653984.

Jackson, S.J. and G.J. Thomas (2017). Human tissue models in cancer research: looking beyond the mouse. Dis Model Mech 10 (8): 939-942. DOI: 10.1242/dmm.031260.

For additional publications, please see Sam's Google Scholar or ResearchGate profile.


PhD, Neurobiology
University College London, 2000-2004
Cannabinoids and neuroprotection in in vivo and in vitro models of multiple sclerosis.
MRes, Neuroscience
University of Manchester, 1999-2000